Table 3:
Post-transplant outcomes and causes of death of lung transplant recipients, 2005-2020.
Variable, n (%) | 18-59 years N=13,228 |
60-69 years N=12,282 |
≥70 years N=2,448 |
p-value |
---|---|---|---|---|
ECMO within 72 hours | 557 (9.0%) | 374 (5.7%) | 79 (4.9%) | <0.001 |
Acute rejection | 1,213 (9.2%) | 914 (7.4%) | 163 (6.7%) | <0.001 |
Post-operative dialysis | 1,006 (7.6%) | 738 (6.0%) | 127 (5.2%) | <0.001 |
Hospital LOS (days), median (IQR) | 17 (12-29) | 16 (11-28) | 16 (11-27) | <0.001 |
Intubation at 72 hours | 2,144 (34.5%) | 1,814 (27.4%) | 353 (21.7%) | <0.001 |
Treated for rejection within 1 year | 3,054 (26.7%) | 2,467 (23.6%) | 442 (21.7%) | <0.001 |
Cause of death by 1 year | <0.001 | |||
Infection | 345 (24.5%) | 469 (28.4%) | 102 (25.6%) | |
Hemorrhage | 209 (14.8%) | 257 (15.6%) | 76 (19.1%) | |
Pulmonary | 212 (15.0%) | 253 (15.3%) | 66 (16.6%) | |
Cardiovascular | 136 (9.6%) | 180 (10.9%) | 49 (12.3%) | |
Malignancy | 34 (2.4%) | 63 (3.8%) | 25 (6.3%) | |
Graft Failure – other | 129 (9.1%) | 104 (6.3%) | 18 (4.5%) | |
Cerebrovascular | 101 (7.2%) | 100 (6.1%) | 14 (3.5%) | |
Graft Failure – rejection | 74 (5.2%) | 61 (3.7%) | 11 (2.8%) | |
Renal Failure | 2 (0.1%) | 13 (0.8%) | 4 (1.0%) | |
Other | 169 (12.0%) | 151 (9.1%) | 33 (8.3%) | |
Cause of death by 5 years | <0.001 | |||
Infection | 785 (18.7%) | 1,050 (22.3%) | 210 (18.9%) | |
Pulmonary | 907 (21.6%) | 857 (18.2%) | 210 (18.9%) | |
Hemorrhage | 569 (13.5%) | 694 (14.7%) | 189 (17.0%) | |
Malignancy | 233 (5.5%) | 499 (10.6%) | 161 (14.5%) | |
Cardiovascular | 246 (5.8%) | 369 (7.8%) | 107 (9.6%) | |
Graft Failure – rejection | 745 (17.7%) | 588 (12.5%) | 97 (8.7%) | |
Graft Failure – other | 210 (5.0%) | 171 (3.6%) | 34 (3.1%) | |
Cerebrovascular | 151 (3.6%) | 156 (3.3%) | 26 (2.3%) | |
Renal Failure | 36 (0.9%) | 62 (1.3%) | 14 (1.3%) | |
Other | 326 (7.7%) | 262 (5.6%) | 66 (5.9%) |
ECMO, extracorporeal membrane oxygenation; LOS, length of stay; IQR, interquartile range.